131 related articles for article (PubMed ID: 12444013)
1. Fatty acid binding protein is a major determinant of hepatic pharmacokinetics of palmitate and its metabolites.
Hung DY; Burczynski FJ; Chang P; Lewis A; Masci PP; Siebert GA; Anissimov YG; Roberts MS
Am J Physiol Gastrointest Liver Physiol; 2003 Mar; 284(3):G423-33. PubMed ID: 12444013
[TBL] [Abstract][Full Text] [Related]
2. Induction of hepatic cytosolic fatty acid binding protein with clofibrate accelerates both membrane and cytoplasmic transport of palmitate.
Luxon BA; Milliano MT; Weisiger RA
Biochim Biophys Acta; 2000 Sep; 1487(2-3):309-18. PubMed ID: 11018482
[TBL] [Abstract][Full Text] [Related]
3. The peroxisomal proliferator clofibrate enhances the hepatic cytoplasmic movement of fatty acids in rats.
Milliano MT; Luxon BA
Hepatology; 2001 Feb; 33(2):413-8. PubMed ID: 11172343
[TBL] [Abstract][Full Text] [Related]
4. Reduced hepatic extraction of palmitate in steatosis correlated to lower level of liver fatty acid binding protein.
Hung DY; Siebert GA; Chang P; Burczynski FJ; Roberts MS
Am J Physiol Gastrointest Liver Physiol; 2005 Jan; 288(1):G93-100. PubMed ID: 15345470
[TBL] [Abstract][Full Text] [Related]
5. Role of fatty acid binding protein on hepatic palmitate uptake.
Burczynski FJ; Zhang MN; Pavletic P; Wang GQ
Can J Physiol Pharmacol; 1997 Dec; 75(12):1350-5. PubMed ID: 9534945
[TBL] [Abstract][Full Text] [Related]
6. Cytosolic fatty acid binding protein enhances rat hepatocyte [3H]palmitate uptake.
Burczynski FJ; Fandrey S; Wang G; Pavletic PA; Gong Y
Can J Physiol Pharmacol; 1999 Nov; 77(11):896-901. PubMed ID: 10593663
[TBL] [Abstract][Full Text] [Related]
7. The hepatocellular transport of sulfobromophthalein-glutathione by clofibrate treated, perfused rat liver.
Sorrentino D; Weisiger RA; Bass NM; Licko V
Lipids; 1989 May; 24(5):438-42. PubMed ID: 2755320
[TBL] [Abstract][Full Text] [Related]
8. Cytochrome P450, peroxisome proliferation, and cytoplasmic fatty acid-binding protein content in liver, heart and kidney of the diabetic rat.
Engels W; van Bilsen M; Wolffenbuttel BH; van der Vusse GJ; Glatz JF
Mol Cell Biochem; 1999 Feb; 192(1-2):53-61. PubMed ID: 10331658
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of binding to fatty acid binding protein reduces the intracellular transport of fatty acids.
Luxon BA
Am J Physiol; 1996 Jul; 271(1 Pt 1):G113-20. PubMed ID: 8760114
[TBL] [Abstract][Full Text] [Related]
10. Effect of fatty acid-binding proteins on intermembrane fatty acid transport studies on different types and mutant proteins.
Veerkamp JH; Van Moerkerk And HT; Zimmerman AW
Eur J Biochem; 2000 Oct; 267(19):5959-66. PubMed ID: 10998056
[TBL] [Abstract][Full Text] [Related]
11. Membrane binding proteins are the major determinants for the hepatocellular transmembrane flux of long-chain fatty acids bound to albumin.
Rajaraman G; Roberts MS; Hung D; Wang GQ; Burczynski FJ
Pharm Res; 2005 Nov; 22(11):1793-804. PubMed ID: 16091995
[TBL] [Abstract][Full Text] [Related]
12. Effect of dexamethasone, 2-bromopalmitate and clofibrate on L-FABP mediated hepatoma proliferation.
Rajaraman G; Burczynski FJ
J Pharm Pharmacol; 2004 Sep; 56(9):1155-61. PubMed ID: 15324484
[TBL] [Abstract][Full Text] [Related]
13. Muscle palmitate uptake and binding are saturable and inhibited by antibodies to FABP(PM).
Turcotte LP; Swenberger JR; Tucker MZ; Yee AJ; Trump G; Luiken JJ; Bonen A
Mol Cell Biochem; 2000 Jul; 210(1-2):53-63. PubMed ID: 10976758
[TBL] [Abstract][Full Text] [Related]
14. Sex differences in intracellular fatty acid transport: role of cytoplasmic binding proteins.
Luxon BA; Weisiger RA
Am J Physiol; 1993 Nov; 265(5 Pt 1):G831-41. PubMed ID: 8238512
[TBL] [Abstract][Full Text] [Related]
15. Acinar heterogeneity of fatty acid binding protein expression in the livers of male, female and clofibrate-treated rats.
Bass NM; Barker ME; Manning JA; Jones AL; Ockner RK
Hepatology; 1989 Jan; 9(1):12-21. PubMed ID: 2642289
[TBL] [Abstract][Full Text] [Related]
16. Effect of palmitic acid and fatty acid binding protein on ventricular fibrillation threshold in the perfused rat heart.
Makiguchi M; Kawaguchi H; Tamura M; Yasuda H
Cardiovasc Drugs Ther; 1991 Aug; 5(4):753-61. PubMed ID: 1888696
[TBL] [Abstract][Full Text] [Related]
17. Fatty acid binding protein: stimulation of microsomal phosphatidic acid formation.
Jolly CA; Hubbell T; Behnke WD; Schroeder F
Arch Biochem Biophys; 1997 May; 341(1):112-21. PubMed ID: 9143360
[TBL] [Abstract][Full Text] [Related]
18. Fatty acid transfer across the myocardial capillary wall: no evidence of a substantial role for cytoplasmic fatty acid-binding protein.
Van Nieuwenhoven FA; Verstijnen CP; Van Eys GJ; Van Breda E; De Jong YF; Van der Vusse GJ; Glatz JF
J Mol Cell Cardiol; 1994 Dec; 26(12):1635-47. PubMed ID: 7731058
[TBL] [Abstract][Full Text] [Related]
19. Expression of recombinant psoriasis-associated fatty acid binding protein in Escherichia coli: gel electrophoretic characterization, analysis of binding properties and comparison with human serum albumin.
Vorum H; Madsen P; Svendsen I; Cells JE; Honoré B
Electrophoresis; 1998 Jul; 19(10):1793-802. PubMed ID: 9719561
[TBL] [Abstract][Full Text] [Related]
20. A null mutation in H-FABP only partially inhibits skeletal muscle fatty acid metabolism.
Binas B; Han XX; Erol E; Luiken JJ; Glatz JF; Dyck DJ; Motazavi R; Adihetty PJ; Hood DA; Bonen A
Am J Physiol Endocrinol Metab; 2003 Sep; 285(3):E481-9. PubMed ID: 12900378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
